Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 6/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17356243 | 1.00 | CYP2A6 (0.48) | CYP2A6CYP1A2TDP1ESR1ESR2 | |
| SCHEMBL21848895 | 0.93 | CYP2A6 (0.45) | CYP2A6CYP1A2TDP1ESR1ESR2 | |
| SCHEMBL17356238 | 0.93 | CYP1A2 (0.40) | CYP2A6CYP1A2TDP1ESR1ESR2 | |
| SCHEMBL17356235 | 0.93 | CYP2A6 (0.45) | CYP2A6CYP1A2TDP1ESR1ESR2 | |
| SCHEMBL17356240 | 0.93 | CYP1A2 (0.40) | CYP2A6CYP1A2TDP1ESR1ESR2 | |
| SCHEMBL18405848 | 0.92 | CYP2A6 (0.56) | CYP2A6CYP1A2TDP1KDM4EGAA | |
| SCHEMBL12433639 | 0.92 | CYP2A6 (0.56) | CYP2A6CYP1A2TDP1KDM4EGAA | |
| SCHEMBL19750022 | 0.92 | CYP2A6 (0.56) | CYP2A6CYP1A2TDP1KDM4EGAA | |
| SCHEMBL21848875 | 0.92 | CYP2A6 (0.56) | CYP2A6CYP1A2TDP1KDM4EGAA | |
| SCHEMBL21848892 | 0.91 | CYP2A6 (0.43) | CYP2A6CYP1A2TDP1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10403828-B2 | Organic compound, and organic thin film and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-09-03 | — | — | US | disclosed |
| US-9985222-B2 | Organic compound, and organic thin film and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-29 | — | — | US | disclosed |
| US-9985222-B2 | Organic compound, and organic thin film and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-29 | — | — | US | disclosed |
| US-20150372241-A1 | ORGANIC COMPOUND, AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
| US-20150372241-A1 | ORGANIC COMPOUND, AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10403828-B2 | Organic compound, and organic thin film and electronic device | OCIAD1, POU2F1, SLCO2A1 | CYP2A6 519/4885CYP1A2 143/4885TDP1 882/4885 |
| US-20150372241-A1 | ORGANIC COMPOUND, AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | OCIAD1, POU2F1, SLCO2A1 | CYP2A6 519/4885CYP1A2 143/4885TDP1 882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.